Age-related macular degeneration, AMD, is the most common cause of vision loss in people over the age of fifty. Yet for many years, the only treatment offered to most people diagnosed with AMD has been a supplement formula that can slow the progression of macular degeneration, but cannot prevent, stop, or reverse AMD and offers no help to those in the earliest stages of the disease. Now, for the first time, is a comprehensive program for the treatment of this all-too common disorder.